• News
    • Opinion Editorial
    • Videos
    • Podcasts
  • Community
    • Members
  • Discussion
  • Groups
    • View All
    • Why Join?
  • Write for us
    Sign in Sign up


    • News
      • Opinion Editorial
      • Videos
      • Podcasts
    • Community
      • Members
    • Discussion
    • Groups
      • View All
      • Why Join?
    • Write for us
    Sign in Sign up

    Tag: University of Cincinnati

    University of Cincinnati Researchers Leveraging CCC19 Identify Higher Risk for Cancer & COVID-19 on Certain Regimens

    University of Cincinnati Researchers Leveraging CCC19 Identify Higher Risk for Cancer & COVID-19 on Certain Regimens

    University of Cincinnati researchers report that certain treatments for cancer could increase the probability of death if the patient contracts COVID-19. Based on a multicenter study,…

    TrialSite Staff
    TrialSite Staff September 20, 2020
    0 Comments
    University of Cincinnati Selected by NIAID as Phase III Clinical Trial Site for mRNA-1273 COVID-19 Vaccine

    University of Cincinnati Selected by NIAID as Phase III Clinical Trial Site for mRNA-1273 COVID-19 Vaccine

    The University of Cincinnati (UC) has been selected by the National Institute of Allergy and Infectious Diseases (NIAID) as a clinical investigational site for the…

    TrialSite Staff
    TrialSite Staff June 18, 2020
    0 Comments
    University of Cincinnati Joins Nationwide Convalescent Plasma Study Targeting COVID-19 Antibodies

    University of Cincinnati Joins Nationwide Convalescent Plasma Study Targeting COVID-19 Antibodies

    The University of Cincinnati College of Medicine and UC Health joined the Mayo Clinic-led research protocol to fight against the spread of COVID-19—the goal: take “convalescent…

    TrialSite Staff
    TrialSite Staff April 18, 2020
    0 Comments
    University of Cincinnati-led Retrospective Study Reveals New Treatment for Patients with Metastatic Melanoma

    University of Cincinnati-led Retrospective Study Reveals New Treatment for Patients with Metastatic Melanoma

    University of Cincinnati researchers have uncovered a potentially more beneficial treatment regimen for patients with metastatic melanoma. The team, in collaboration with a group at Winship…

    TrialSite Staff
    TrialSite Staff February 27, 2020
    0 Comments
    University of Cincinnati Investigator Fails to Seek Timely Approval tied to Human-Studies

    University of Cincinnati Investigator Fails to Seek Timely Approval tied to Human-Studies

    A University of Cincinnati (UC) principal investigator failed to properly seek approval tied to the rights and welfare of human research subjects, according to the…

    TrialSite Staff
    TrialSite Staff December 13, 2019
    0 Comments
    Medical Healthcare Research and Development Concept.

    UC Health Announces First VP and Chief Analytics Officer to Drive Data-Driven Innovation

    UC Health named Michael Legg, MHA, chief data and analytics officer for the bustling regional academic health system to drive a culture of data-driven innovation.…

    TrialSite Staff
    TrialSite Staff July 2, 2019
    0 Comments

    Read more about…

    Alzheimer Alzheimer's Disease Artificial Intelligence Autoimmune Disease Breast Cancer Cancer Cardiovascular Challenging Results China Clinical Research Clinical Research as a Care Option Clinical Trials CNS Coronavirus covid-19 COVID-19 Dementia Diabetes Digital Health Digital Media FDA Gene Therapy Immunotherapy India Investigator Content Investigator Profiles Investor Watch Ivermectin Leading Pharma Leading Sites Neurology NIH Oncology Patient Recruitment Pharma Watch Positive Results Price Watch Prostate Cancer Research SARS-CoV-2 Site Challenges Site Success Site Watch UK Vaccine

    About Us

    TRIALSITE NEWS IS  DEDICATED TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

    © 2021 - Trial Site News
    • Terms of Service
    • Privacy Policy

    TrialSite News
    159 W Broadway, Suite 200
    Salt Lake City, UT 84101

    Report Content

    Harassment or bullying behavior
    Contains mature or sensitive content
    Contains misleading or false information
    Contains abusive or derogatory content
    Anything overly promotional selling products or services

    Block Member?

    Please confirm you want to block this member.

    You will no longer be able to:

    • See blocked member's posts
    • Mention this member in posts
    • Invite this member to groups
    • Message this member
    • Add this member as a connection

    Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.